Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Foster

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer|March 15, 1985
Adverse relationship between blood transfusions and survival after colectomy for colon cancerR S Foster, M C Costanza, J C Foster, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1991
Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariaeC B Foster, T P Flanigan, J W Kazura, et al.
Journal of Orthopaedic Trauma|January 27, 2018
Soft Tissue Structures Differ in Patients With Prearthritic Hip DiseaseAnne Le Bouthillier, Kawan S Rakhra, Etienne L Belzile, et al.
Transplantation Proceedings|December 1, 1988
Blood transfusions and survival after resection of cancers of the breast, colon, and lung: the need for prospective randomized trialsR S Foster, M Costanza, J C Foster, et al.
Blood|December 10, 1999
Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populationsT Lehrnbecher, C B Foster, S Zhu, et al.
Genes and Immunity|August 31, 2001
Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South IndiaE H Choi, P A Zimmerman, C B Foster, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1992
Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoniC B Foster, T P Flanigan, K K DeStigter, et al.
Clinical and Experimental Immunology|July 11, 2000
Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathiesL G Rider, C M Artlett, C B Foster, et al.
Blood|September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusC B Foster, T Lehrnbecher, S Samuels, et al.
The Journal of Clinical Investigation|December 17, 1998
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous diseaseC B Foster, T Lehrnbecher, F Mol, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer|March 15, 1985
Adverse relationship between blood transfusions and survival after colectomy for colon cancerR S Foster, M C Costanza, J C Foster, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1991
Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariaeC B Foster, T P Flanigan, J W Kazura, et al.
Journal of Orthopaedic Trauma|January 27, 2018
Soft Tissue Structures Differ in Patients With Prearthritic Hip DiseaseAnne Le Bouthillier, Kawan S Rakhra, Etienne L Belzile, et al.
Transplantation Proceedings|December 1, 1988
Blood transfusions and survival after resection of cancers of the breast, colon, and lung: the need for prospective randomized trialsR S Foster, M Costanza, J C Foster, et al.
Blood|December 10, 1999
Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populationsT Lehrnbecher, C B Foster, S Zhu, et al.
Genes and Immunity|August 31, 2001
Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South IndiaE H Choi, P A Zimmerman, C B Foster, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1992
Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoniC B Foster, T P Flanigan, K K DeStigter, et al.
Clinical and Experimental Immunology|July 11, 2000
Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathiesL G Rider, C M Artlett, C B Foster, et al.
Blood|September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusC B Foster, T Lehrnbecher, S Samuels, et al.
The Journal of Clinical Investigation|December 17, 1998
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous diseaseC B Foster, T Lehrnbecher, F Mol, et al.
Pageof 3